IP Library Granted Patent US 7,947,471
Granted Patent B2
US 7,947,471 · App. 11/851,549 · Granted May 24, 2011

Method of production of recombinant proteins in eukaryote cells

Assignee: Novo Nordisk Health Care A/G
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,947,471
App. No.
11/851,549
Granted
May 24, 2011
Kind
B2
Abstract

The invention provides a method for production of polypeptides in eukaryote microcarrier cell culture, the method comprising the steps of (i) Culturing cells expressing said polypeptide on microcarriers under conditions and at a setpoint temperature appropriate for expression of said polypeptide; (ii) Cooling the culture to a predetermined temperature below said setpoint; (iii) Sedimenting the microcarriers; and (iv) Harvesting all or part of the culture medium.

Claims (14)

1. A method for production of a Factor VII polypeptide in eukaryote cells, comprising the steps of

(i) culturing cells expressing a Factor VII polypeptide on microcarriers under conditions and at a setpoint temperature appropriate for expression of said Factor VII polypeptide;

(ii) actively cooling the culture to a predetermined temperature prior to step (iii), wherein the predetermined temperature is −10° C. below the setpoint;

(iii) sedimenting the microcarriers; and

(iv) harvesting all or part of the culture medium thereby producing said Factor VII polypeptide thereby producing said Factor VII polypeptide.

2. The method according to claim 1 , further comprising a step of adding fresh medium to the culture after said harvesting.

3. The method according to claim 1 , further comprising a step of recovering said polypeptide from the harvested culture medium.

4. The method according to claim 1 , wherein the culture is cooled to a temperature from 25° C. to 27° C.

5. The method according to claim 1 , wherein the eukaryote cells are insect cells.

6. The method according to claim 1 , wherein the eukaryote cells are mammalian cells.

7. The method according to claim 6 , wherein the mammalian cells are selected from the group consisting of human embryonic kidney (HEK), baby hamster kidney (BHK), and Chinese hamster ovary (CHO) cells.

8. The method according to claim 7 , wherein the mammalian cells are CHO cells.

9. The method according to claim 1 , wherein the Factor VII polypeptide is produced at a level at least 15 mg/l of culture.

10. The method according to claim 1 , wherein the Factor VII polypeptide is human Factor VII, the cells are CHO cells, the microcarriers are macroporous carriers, the set-point temperature is 36° C., and the culture is cooled to 26° C. before allowing the microcarriers to sediment.

Assignments (1)
CHANGE OF ADDRESS Recorded Jun 19, 2013
From: NOVO NORDISK HEALTHCARE A/G
To: NOVO NORDISK HEALTHCARE AG
Reel/Frame 030653/0189 →
Continuity (2)
Continuation 11429558 · May 5, 2006
Related Publication 20080064068A1 · Mar 13, 2008